ArticleCureus2025
Acute Liver Failure Secondary to Primary Large B-cell Lymphoma Complicated by Malignancy-related Hemophagocytic Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute liver failure is a catastrophic condition characterized by the sudden and severe impairment of hepatic function. We report the case of a 36-year-old patient who presented with significant dehydration, generalized jaundice, evidence of hepatic encephalopathy, generalized edema with abdominal distension, and hepatosplenomegaly. A liver biopsy was performed, yielding the final diagnosis of primary large B-cell lymphoma. Subsequently, a bone marrow aspirate and biopsy were performed, confirming the diagnosis of hemophagocytic syndrome. The patient was managed with R-CHOEP (rituximab, cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone) chemotherapy. After 21 days, the patient was successfully discharged to continue treatment on an outpatient basis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.